Home » CARDIOGENESIS REPORTS 2005 FOURTH QUARTER, YEAR-END RESULTS
CARDIOGENESIS REPORTS 2005 FOURTH QUARTER, YEAR-END RESULTS
Cardiogenesis Corporation, the market leader in surgical products and accessories
used in angina-relieving Transmyocardial Revascularization (TMR) and Percutaneous
Myocardial Channeling procedures, announced results today for its fourth quarter
and year ended December 31, 2005.
MSN
Money
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May